- Success Stories
CTIS will be the single-entry point for submitting, assessing, authorising, supervising and reporting a clinical trial in all Member States of the EU.
The system is currently under development, with PSNResearch as member of the working group since 2017, and will have collaboration and communication tools, workflow and document management capabilities.
It will include a user management tool to enable access for sponsors, Member States and the European Commission via dedicated workspaces. It will also provide general public with access to clinical trials information.
CTIS will centralise the submission process for clinical trial applications and the assessment and authorisation by Member States in a single unique platform.
These are CTIS new features:
The sooner your organization adapts to CTIS, the sooner you will get the cost reduction it will bring. In addition, it will help you avoid future (complex and expensive) migrations. At PSNResearch, we have been already working with CTIS for the last five years and are certified by EMA as CTIS Master Trainer.